Flu Vaccine Market Report

Flu Vaccine Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 20, 2020
  • PAGES：176
  • REPORT CODE：GMM442641
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Flu Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.4% during the forecast period.

    This report presents the market size and development trends by detailing the Flu Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Flu Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Flu Vaccine industry and will help you to build a panoramic view of the industrial development.

    Flu Vaccine Market, By Type:

    • Market by Ofvaccines

    • Fluzone/Vaxigrip

    • Anflu

    • FluMist

    • Fluarix

    • FluLaval

    • Fluvax/Afluria

    • Fluvirin

    • Others

    Flu Vaccine Market, By Application:

    • Pediatrics

    • Adults

    Some of the leading players are as follows:

    • Pfizer

    • Johnson & Johnson

    • Serum Institute of India

    • MedImmune, LLC

    • Sinovac Biotech

    • ID Biomedical Corporation

    • Sanofi Pasteur

    • Protein Sciences Corporaton

    • Novartis

    • Mylan

    • GSK

    • Hualun Biologicalsamong

    • CSL Limited

    • AstraZeneca

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Flu Vaccine Market: Technology Type Analysis

    • 4.1 Flu Vaccine Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Flu Vaccine Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Market by Ofvaccines

      • 4.3.2 Fluzone/Vaxigrip

      • 4.3.3 Anflu

      • 4.3.4 FluMist

      • 4.3.5 Fluarix

      • 4.3.6 FluLaval

      • 4.3.7 Fluvax/Afluria

      • 4.3.8 Fluvirin

      • 4.3.9 Others

    5 Flu Vaccine Market: Product Analysis

    • 5.1 Flu Vaccine Product Market Share Analysis, 2018 & 2026

    • 5.2 Flu Vaccine Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Flu Vaccine Market: Application Analysis

    • 6.1 Flu Vaccine Application Market Share Analysis, 2018 & 2026

    • 6.2 Flu Vaccine Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pediatrics

      • 6.3.2 Adults

    7 Flu Vaccine Market: Regional Analysis

    • 7.1 Flu Vaccine Regional Market Share Analysis, 2018 & 2026

    • 7.2 Flu Vaccine Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Pfizer

      • 9.1.1 Pfizer Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Johnson & Johnson

      • 9.2.1 Johnson & Johnson Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Serum Institute of India

      • 9.3.1 Serum Institute of India Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 MedImmune, LLC

      • 9.4.1 MedImmune, LLC Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Sinovac Biotech

      • 9.5.1 Sinovac Biotech Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 ID Biomedical Corporation

      • 9.6.1 ID Biomedical Corporation Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Sanofi Pasteur

      • 9.7.1 Sanofi Pasteur Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Protein Sciences Corporaton

      • 9.8.1 Protein Sciences Corporaton Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Novartis

      • 9.9.1 Novartis Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Mylan

      • 9.10.1 Mylan Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 GSK

      • 9.11.1 GSK Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Hualun Biologicalsamong

      • 9.12.1 Hualun Biologicalsamong Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 CSL Limited

      • 9.13.1 CSL Limited Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 AstraZeneca

      • 9.14.1 AstraZeneca Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

     

    The List of Tables and Figures (Totals 89 Figures and 125 Tables)

    • Figure Market by Ofvaccines Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Fluzone/Vaxigrip Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Anflu Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure FluMist Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Fluarix Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure FluLaval Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Fluvax/Afluria Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Fluvirin Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Others Flu Vaccine market, 2015 - 2026 (USD Million)

    • Figure Pediatrics market, 2015 - 2026 (USD Million)

    • Figure Adults market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Flu Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Canada Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Canada Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Germany Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Germany Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table France Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table France Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Italy Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Italy Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Spain Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Spain Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table China Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table China Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Japan Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Japan Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table India Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table India Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Flu Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Flu Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Flu Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table MedImmune, LLC Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sinovac Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ID Biomedical Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Protein Sciences Corporaton Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hualun Biologicalsamong Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CSL Limited Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US